The Journal of Urology
Volume 182, Issue 5 , Page 2121 , November 2009

Editorial Comment

References 

  1. Willems AJ, Dawson SJ, Samaratunga H, et al. Loss of heterozygosity at the BRCA2 locus detected by multiplex ligation-dependent probe amplification is common in prostate cancers from men with a germline BRCA2 mutation. Clin Cancer Res. 2008;14:2953
  2. Mitra A, Fisher C, Foster CS, et al. Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype. Br J Cancer. 2008;98:502
  3. Hessels D, Schalken JA. The use of PCA3 in the diagnosis of prostate cancer. Nat Rev Urol. 2009;6:255

PII: S0022-5347(09)02127-2

doi: 10.1016/j.juro.2009.07.151

The Journal of Urology
Volume 182, Issue 5 , Page 2121 , November 2009

Article Tools